Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Aug 2;22(11):2019–2024. doi: 10.1016/j.bbmt.2016.07.019

Figure 1.

Figure 1

Significant study outcomes stratified by UCB unit–recipient ABO-compatibility status. Kaplan-Meier and cumulative incidence curves for significant study outcomes stratified by unit–recipient ABO mismatch groups. Top (left to right): Overall survival, graft failure, and grades III to IV aGVHD. Bottom (left to right): Time to absolute neutrophil count (ANC) recovery, time to platelet transfusion independence, and cumulative proportion of cGVHD.